
Euroapi Investor Relations Material
Latest events

AGM 2025
Euroapi
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Euroapi S.A.
Access all reports
Euroapi S.A., operating under the brand EUROAPI, is a global leader in the production of active pharmaceutical ingredients (APIs). The company boasts an extensive portfolio of over 200 products, serving the healthcare industry by developing, manufacturing, and distributing APIs and intermediates. These ingredients are crucial for the formulation of medicines intended for both human and veterinary use, catering to a broad spectrum of therapeutic areas including small molecules, lipids, microbial fermentation, and more. EUROAPI's offerings also encompass Contract Development and Manufacturing Organization (CDMO) services. The company is headquartered in Paris, France, and its shares are listed on the Euronext Paris stock exchange.
Key slides for Euroapi S.A.


H1 2024
Euroapi S.A.


H2 2024
Euroapi S.A.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
EAPI
Country
🇫🇷 France